Abera Bioscience AB is a Swedish biotech company headquartered in Uppsala. We are dedicated to develop novel mucosal vaccines based on proprietary vaccine platforms to improve health worldwide. Abera's platforms allows the development of efficient multivalent, multi-stage vaccines for oral and nasal administration. It also enables faster and more cost-effective production. Abera's OMV-based vaccines can be manufactured within 14-30 days.
Looking for a particular Abera Bioscience AB employee's phone or email?
Abera Bioscience AB Questions
The Abera Bioscience AB annual revenue was $5 million in 2026.
Maria Alriksson is the CEO of Abera Bioscience AB.
14 people are employed at Abera Bioscience AB.
Abera Bioscience AB is based in Uppsala, Uppsala County.
The NAICS codes for Abera Bioscience AB are [541, 5417, 54, 54171, 541713].
The SIC codes for Abera Bioscience AB are [87, 873].
Top Abera Bioscience AB Employees
-
22
-
Joen Luirink
Chief Technology Officer at Abera Bioscience AB
Amsterdam, NH, NL15+ -
Fredrik Juserius
Board Member at Abera Bioscience AB
Stockholm, SE2 -
Ann-Christin Magnusson
Lab Manager at Abera Bioscience AB
Uppsala, Uppsala County, SE1 -
Wouter Jong
Senior Project Manager and Research and Development at Abera Bioscience AB
Amsterdam, North Holland, Netherlands -
Jessica Pettersson
Research Engineer at Abera Bioscience AB
Uppsala, Uppsala County, SE1 -
Bart Saparoea
Senior Wetenschapper at Abera Bioscience AB
Amsterdam, North Holland, Netherlands2
Related Companies
